TP73 and neoplasm: Due to the usage of two different promoters, TP73 is transcribed as two isoforms, the full-length TAp73 isoforms that exhibit tumor suppressor activity and the N-terminally truncated ΔNp73 isoforms that exhibit oncogenic activity [3,5,6].